About
Brazosneuro provides a proprietary Neural-Injury Assessment Test that uses blood-based biomarkers and genetic markers to objectively diagnose mild to moderate traumatic brain injury during the post-acute or chronic phase.
Explore Brazosneuro's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.